I'm LongbridgeAI, I can summarize articles.Beijing Tong Ren Tang Healthcare (HK:2667) announced that its IPO stabilization period ended on August 1, 2026. The stabilizing manager purchased 5,407,500 H shares between HK$2.69 and HK$4.76 to support the price. The over-allotment option has lapsed unexercised. The company confirmed it continues to meet Hong Kong public float requirements. Trading will now fully reflect market forces.
Beijing Tong Ren Tang Healthcare Investment Co. Ltd. Class H ( (HK:2667) ) just unveiled an update.
Beijing Tong Ren Tang Healthcare Investment Co., Ltd. reported that the stabilization period for its recent global share offering ended on 1 August 2026, with China International Capital Corporation Hong Kong Securities Limited conducting over-allocation and subsequent market purchases of 5,407,500 H shares, about 5 percent of the initial offer size. The over-allotment option was not exercised and has lapsed, and the company confirmed it continues to meet Hong Kong public float requirements, providing clarity on post-listing share dynamics and regulatory compliance for investors.
The stabilizing manager bought shares in the range of HK$2.69 to HK$4.76, with the last purchase at HK$2.79 on 31 July 2026, smoothing price movements during the stabilization window. With the end of these interventions and the lapse of the over-allotment option, trading in the company’s H shares will now fully reflect market forces, an important milestone for shareholders monitoring liquidity and price stability.
More about Beijing Tong Ren Tang Healthcare Investment Co. Ltd. Class H
Beijing Tong Ren Tang Healthcare Investment Co., Ltd. is a joint stock company incorporated in the People’s Republic of China with limited liability, listed in Hong Kong under stock code 2667. The company operates in the healthcare sector, leveraging the Tong Ren Tang brand, and accesses international capital markets through H-share listings aimed at global investors.
Average Trading Volume: 3,938,225
Current Market Cap: HK$604.7M
For a thorough assessment of 2667 stock, go to TipRanks’ Stock Analysis page.